Sunday - December 22, 2024

Non-Recombinant Human Insulin-Like Growth Factor Binding Protein Concentrate

2024-12-10

ALEXANDRIA, Virginia, Dec. 10 -- SIEMENS HEALTHCARE DIAGNOSTICS INC., Tarrytown, New York has been assigned a patent (No. US 12167255 B2, initially filed Nov. 16, 2020) developed by ten inventors Spencer Lin, Walnut Creek, California; Kwasi Osae-Kwapong, White Plains, New York; Omar Quraishi, Maplewood, New Jersey; Seema Sinha, Rancho Santa Margarita, California; Michele Smith, Poughkeepsie, New York; SunRay DiFrancesco, Peekskill, New York; Ryan Spears, Stamford, Connecticut; Dharini Rawal, Was . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Non-Recombinant Human Insulin-Like Growth Factor Binding Protein Concentrate

Information Request Form

Copyright Targeted News Service 2024